黃 柏勳

Medicine & Life Sciences

1. Endothelial Progenitor Cells 100%
2. Coronary Artery Disease 39%
3. Taiwan 26%
4. Myocardial Infarction 24%
5. Serum 20%
6. Ischemia 19%
7. Atrial Fibrillation 16%
8. Kidney 16%
9. Cardiovascular Diseases 15%
10. Stroke 15%
11. Arteriovenous Fistula 15%
12. Coronary Angiography 15%
13. Blood Vessels 14%
14. Blood Pressure 14%
15. activin A 13%
16. Population 13%
17. Indican 13%
18. Nitric Oxide Synthase Type III 13%
19. Atherosclerosis 13%
20. Heart Failure 13%
21. C-Reactive Protein 13%
22. Mortality 12%
23. Percutaneous Coronary Intervention 12%
24. Galectin 1 12%
25. Matrix Metalloproteinase 9 12%
26. Ginkgo biloba extract 11%
27. Glucose 11%
28. Renal Dialysis 11%
29. magnolol 11%
30. Albuminuria 10%
31. Cohort Studies 10%
32. Inflammation 10%
33. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
34. Hypertension 10%
35. Glomerular Filtration Rate 10%
36. fibroblast growth factor 21 9%
37. Central Serous Chorioretinopathy 9%
38. Longitudinal Studies 9%
39. Abdominal Aortic Aneurysm 9%
40. Hindlimb 9%
41. Bilirubin 8%
42. Podocytes 8%
43. Vasodilation 8%
44. National Health Programs 8%
45. Matrix Metalloproteinases 7%
46. Thrombosis 7%
47. Endothelial Cells 7%
48. Tumor Necrosis Factor-alpha 7%